The Development of Vaccine Against Parasite Infection

Dear Colleagues,

Parasitic infections affect over three billion people worldwide, leading to significant morbidity and mortality. For over 100 years, the mass administration of anti-parasitic drugs, combined with improved vector control and sanitation measures, has significantly reduced infections, leading to improved health outcomes. However, the rising incidence of anti-parasitic medicines and insecticide resistance threaten the effectiveness of these measures. Vaccines have been used to prevent infections and reduce the burden of disease for over 200 years; however, the only antiparasitic vaccine licensed for clinical use is the RTS, S/AS01 malaria. Therefore, there is an urgent to develop vaccines that target parasitic infections. This Special Issue will focus on several factors that affect the development of vaccines for parasitic diseases, including needs assessments, novel vaccine candidates, adjuvant and delivery system technologies that enhance development strategies, and reviews providing an overview of the current status of the field.

Dr. Kathryn M. Jones
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.